Conference abstract · 25 Jul 2019
Review articlePublished 2020
C2AZ as treatment adjunct
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This paper is a technical note showing how the established pharmacodynamic actions of four non-oncology drugs happen to inhibit several established pathophysiological mechanisms active in driving or facilitating breast cancers’ growth. The resulting four repurposed drug regimen, C2AZ, uses the analgesic drug celecoxib; the antifungal drug clotrimazole; a drug used to treat rheumatoid arthritis, auranofin; and a drug used to treat asthma, zileuton. All four have a large database showing that they inhibit one or more growth driving pathways of breast cancer. The four drugs of C2AZ have been well tolerated in general medical practice and no drug-drug interaction is predictable. All four are old, cheap, generic drugs. They are predicted to be growth retarding rather than directly cytotoxic so C2AZ would best be studied in an adjunctive role.This paper is a technical note showing how the established pharmacodynamic actions of four non-oncology drugs happen to inhibit several established pathophysiological mechanisms active in driving or facilitating breast cancers’ growth. The resulting four repurposed drug regimen, C2AZ, uses the analgesic drug celecoxib; the antifungal drug clotrimazole; a drug used to treat rheumatoid arthritis, auranofin; and a drug used to treat asthma, zileuton. All four have a large database showing that they inhibit one or more growth driving pathways of breast cancer. The four drugs of C2AZ have been well tolerated in general medical practice and no drug-drug interaction is predictable. All four are old, cheap, generic drugs. They are predicted to be growth retarding rather than directly cytotoxic so C2AZ would best be studied in an adjunctive role.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2018
Flax lignan and its mammalian lignans for breast cancer prevention, and adjunct therapy to halt metastasis
Mini review · 29 Feb 2024
Acupuncture as an Adjunct Therapy for Cancer-Related Pain
Conference abstract · 5 Dec 2016
Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients – A pragmatic randomized controlled trial
Review article · 2015
Physical Therapy Interventions are Beyond Adjunct Care in Improving Quality of Life and Alleviating Pain Related to Cancer and its Treatment: Perspectives and Confronts
More from this journal
The newest in Translational Biomedicine.
Research article · 30 Dec 2024
An Examination of the Correlation between Advancements in TBI Research and the Long-Term Health Outcomes of High-Risk Populations: The Use of Biomarkers vs. Symptom Assessment
Perspective · 20 Dec 2024
Preclinical and Animal Studies in Translational Biomedicine: Bridging the Gap Between Bench and Bedside
Perspective · 20 Dec 2024
Regenerative Medicine in Translational Biomedicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Biomedicine
- SubjectOncology & Cancer
- BylineArticles whose byline prints “R.E. Kast”

